Lisa Durkin

Cleveland Clinic — United States

Medicine · Health Sciences

18h-index1.5kcitations55works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(23), Chronic Lymphocytic Leukemia Research(16), Acute Myeloid Leukemia Research(8), Viral-associated cancers and disorders(7), CAR-T cell therapy research(6)

Publications55 total

Angioimmunoblastic T‐cell lymphoma: Characterization of clonal T and B cells and a patient‐derived xenograft study of coexisting T‐ and B‐cell proliferation
eJHaem·2025· 1 citedOpen Access
Ki67 proliferation index in follicular lymphoma is associated with favorable outcome in patients treated with R-CHOP
Leukemia & lymphoma/Leukemia and lymphoma·2023· 7 cited
Supplementary Figure Legends from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Table S1 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Table S1 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Supplementary Figure Legends from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Supplementary Figures S1-S7 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Data from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Data from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
Supplementary Figures S1-S7 from LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
2023Open Access
The clinicopathologic significance of <scp><i>NPM1</i></scp> mutation and ability to detect mutated <scp>NPM1</scp> by immunohistochemistry in <scp>non‐AML</scp> myeloid neoplasms
Genes Chromosomes and Cancer·2023· 4 citedOpen Access
Immune Escape Mechanisms in Intravascular Large B-Cell Lymphoma: A Molecular Cytogenetic and Immunohistochemical Study
American Journal of Clinical Pathology·2021· 9 cited
IgM Plasma Cell Myeloma
American Journal of Clinical Pathology·2021· 9 cited
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies
Blood·2021· 87 citedOpen Access
Decreased BIM expression in BCL2-negative follicular lymphoma: a potential mechanism for resistance to apoptosis
Human Pathology·2020· 6 cited
Lack of activation-induced cytidine deaminase expression in in situ follicular neoplasia
Haematologica·2020· 3 citedOpen Access
Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcomas of the Spleen Are EBV-Associated and Lack Other Commonly Identifiable Molecular Alterations
International Journal of Surgical Pathology·2020· 18 cited
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network
Leukemia·2020· 99 citedOpen Access
Inhibition of cyclin‐dependent kinase 9 synergistically enhances venetoclax activity in mantle cell lymphoma
eJHaem·2020· 6 citedOpen Access
Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network
2020· 3 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Eric D. Hsi(47), Juraj Bodo(23), Xiaoxian Zhao(16), Mien Sho(10), Debra T. Chao(10), Jaroslaw P. Maciejewski(9), James W. Purcell(8), Sonia G. Tanlimco(8), Jonathan A. Hickson(8), Diane Hollenbaugh(8), Kurt Gish(8), Susan E. Morgan-Lappe(8), Melvin Fox(7), Tamar Uziel(7), Rick Powers(7), Thomas McGonigal(7), Subashri Kumar(7), Josue Samayoa(7), Joann P. Palma(7), Sarah L. Ondrejka(7)